Adagrasib
ATC L01XX77 · 4 markets · 4 records
US 1 records · 1 strengths
- 200 mgtabletKRAZATI
TW 1 records · 1 strengths
- 200 mgtabletKRAZATI達再樂膜衣錠200毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 KRAZATI
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 KRAZATI
| Strength / form / release | US | TW | HK | EU |
|---|---|---|---|---|
| 200 mg tablet | KRAZATI | KRAZATI 達再樂膜衣錠200毫克 | ||
unknown | KRAZATI | KRAZATI |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.